Presentation ESC 2025 ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation Presenter: Jonas Oldgren August 30, 2025
Presentation TCT India 2025 Embolic Protection in TAVR: Present Status and Future Presenter: Samir Kapadia July 27, 2025
Presentation TCT India 2025 Acute Stroke Interventions – Newer Improvements Presenter: Anshu Mahajan July 26, 2025
Presentation NY Valves 2025 Sentinel Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis of Randomized Controlled Trials Presenter: Sunny Goel June 27, 2025
Presentation NY Valves 2025 Impact of Prior History of Stroke on Clinical Outcomes in Patients With Severe Aortic Stenosis Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Presenter: Ogechukwu Samuel Obi June 27, 2025
Presentation NY Valves 2025 Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture Presenter: Adnan K. Chhatriwalla June 27, 2025
Presentation NY Valves 2025 Anatomic Correlation Between Noninvasive and Invasive Angiogram on the Use of Cerebral Embolic Protection Devices in TAVR: A Real-world Experience From a Single Tertiary Care Center Presenter: Bhavanadhar Penta June 27, 2025
Presentation NY Valves 2025 My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation? Presenter: Matthew J. Price June 26, 2025
Presentation NY Valves 2025 Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice Presenter: Alexandra J. Lansky June 26, 2025
Presentation NY Valves 2025 Latest Clinical Insights: Bridging Evidence and Practice Presenter: Samir R. Kapadia June 25, 2025
Presentation NY Valves 2025 Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry Presenter: David J. Cohen June 25, 2025
Presentation NY Valves 2025 Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection Presenter: Suzanne J. Baron June 25, 2025
Presentation THT 2025 Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis Presenter: Anthony Carnicelli February 11, 2025
Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
Presentation TCT 2024 TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level Presenter: G. Michael Deeb October 30, 2024
Presentation TCT 2024 TCT 850: Impact of Repositioning on Brain Injury Following Transcatheter Aortic Valve Replacement With a Self-Expanding Valve Presenter: Jiaqi Fan October 30, 2024
Presentation TCT 2024 TCT 849: Stroke in TAVR Patients Undergoing Procedures With Recapturable Valves: A Meta-Analysis Presenter: Dan Haberman October 30, 2024
Presentation TCT 2024 TCT 848: Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement: Periprocedural Changes and Predictors of Improvement Presenter: Srini Potluri October 30, 2024
Presentation TCT 2024 TCT 847: Trends in Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample Presenter: Jerry Lipinski October 30, 2024